Serum amyloid A and protein AA: Molecular mechanisms of a transmissible amyloidosis

FEBS Letters

Volumn 583, Issue 16, 2009, Pages 2685-2690

  Westermark, Gunilla T ^a,b   Westermark, Per ^c  

^a Diabetes Research Centre   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amyloid; Fibril; Prion; Seeding; Transmission

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID; AMYLOID A PROTEIN; PRION PROTEIN;

ACUTE PHASE RESPONSE; AMYLOIDOSIS; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; GENE OVEREXPRESSION; HUMAN; INOCULATION; MOLECULAR MECHANICS; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN INDUCTION; RISK FACTOR; SHORT SURVEY; TISSUE REPAIR;

AMYLOID; AMYLOIDOSIS; ANIMALS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INFLAMMATION; MICE; PRIONS; SERUM AMYLOID A PROTEIN;

MUS;

EID: 68649103960     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.04.026     Document Type: Short Survey

References (76)

1. Glenner G.G. Amyloid deposits and amyloidosis. The β-fibrilloses. New Engl. J. Med. 302 (1980) 1283-1292 1333-1343
2. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J. 272 (2005) 5942-5949
3. Westermark P., Benson M.D., Buxbaum J.N., Cohen A.S., Frangione B., Ikeda S.-I., Masters C.L., Merlini G., Saraiva M.J., and Sipe J.D. A primer of amyloid nomenclature. Amyloid 14 (2007) 179-183
4. Husby G., Marhaug G., Dowton B., Sletten K., and Sipe J.D. Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid: Int. J. Exp. Clin. Invest. 1 (1994) 119-137
5. Wang S., Murphy C.L., Kestler D., Macy S.D., Williams T.K., Weiss D.T., and Solomon A. SAA4-related AA amyloidosis. In: Skinner M., Berk J.L., Connors L.H., and Seldin D.C. (Eds). XIth International Symposium on Amyloidosis (2008), CRC Press, Boca Raton, FL 105-107
6. Eriksen N., and Benditt E.P. Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein. Proc. Natl. Acad. Sci. USA 77 (1980) 6860-6864
7. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265 (1999) 501-523
8. McAdam K.P.W.J. Leprosy, filariasis and malaria as causes of secondary amyloidosis in the tropics. Papua New Guinea Med. J. 21 (1978) 69-78
9. McAdam K.P.W.J., Raynes J.G., Alpers M.P., Westermark G.T., and Westermark P. Amyloidosis: a global problem common in Papua New Guinea. Papua New Guinea Med. J. 39 (1996) 284-296
10. van der Hilst J.C., Simon A., and Drenth J.P. Hereditary periodic fever and reactive amyloidosis. Clin. Exp. Med. 5 (2005) 87-98
11. Gajdusek D.C., and Zigas V. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. New Engl. J. Med. 257 (1957) 974-978
12. Gajdusek D.C., and Zigas V. Kuru. Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among the natives of the Eastern Highlands of New Guineas. Am. J. Med. 26 (1959) 442-469
13. Zigas V., and Gajdusek D.C. Kuru. Clinical, pathological and epidemiological study of a recently discovered acute progressive degenerative disease of the central nervous system reaching "epidemic" proportions among natives of the Eastern Highlands of New Guinea. Papua New Guinea Med. J. 3 (1959) 1-24
14. Klatzo I., Gajdusek D.C., and Zigas V. Pathology of kuru. Lab. Invest. 8 (1959) 799-847
15. Gajdusek D.C., Gibbs Jr. C.J., and Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 209 (1966) 794-796
16. Gibbs Jr. C.J., Amyx H.L., Bacote A., Masters C.L., and Gajdusek D.C. Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J. Infect. Dis. 142 (1980) 205-208
17. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
18. Werdelin O., and Ranløv P. Amyloidosis in mice produced by transplantation of spleen cells from casein-treated mice. Acta Path. Microbiol. Scand. 68 (1966) 1-18
19. Axelrad M.A., Kisilevsky R., Willmer J., Chen S.J., and Skinner M. Further characterization of amyloid-enhancing factor. Lab. Invest. 47 (1982) 139-146
20. Pras M., Schubert M., Zucker-Franklin D., Rimon A., and Franklin E.C. The characterization of soluble amyloid prepared in water. J. Clin. Invest. 47 (1968) 924-933
21. Brissette L., Young I., Narindrasorasak S., Kisilevsky R., and Deeley R. Differential induction of the serum amyloid A gene family in response to an inflammatory agent and to amyloid-enhancing factor. J. Biol. Chem. 264 (1989) 19327-19332
22. Lundmark K., Westermark G.T., Nyström S., Murphy C.L., Solomon A., and Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA 99 (2002) 6979-6984
23. Jarrett J.T., and Lansbury P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimeŕs disease and scrapie?. Cell 73 (1993) 1055-1058
24. Kelly J.W., and Lansbury P.T.J. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation. Amyloid 1 (1994) 186-205
25. Pepys M.B., Rademacher T.W., Amatayakul-Chantler S., Williams P., Noble G.E., Hutchinson W.L., Hawkins P.N., Nelson S.R., Gallimore J.R., Herbert J., Hutton T., and Dwek R.A. Human serum amyloid P component is an invariant constituent of amyloid deposits and has uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91 (1994) 5602-5606
26. Kisilevsky R. Review: amyloidogenesis - unquestioned answers and unanswered questions. J. Struct. Biol. 130 (2000) 99-108
27. Gellermann G.P., Appel T.R., Tannert A., Radestock A., Hortschansky P., Schroeckh V., Leisner C., Lutkepohl T., Shtrasburg S., Rocken C., Pras M., Linke R.P., Diekmann S., and Fändrich M. Raft lipids as common components of human extracellular amyloid fibrils. Proc. Natl. Acad. Sci. USA 102 (2005) 6297-6302
28. Gajdusek D.C. Kuru and its contribution to medicine. Phil. Trans. R. Soc. B 363 (2008) 3697-3700
29. Brown P., Rau E.H., Johnson B.K., Bacote A.E., Gibbs C.J.J., and Gajdusek D.C. New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 C suggests an inorganic template of replication. Proc. Natl. Acad. Sci. USA 97 (2000) 3418-3421
30. Niewold T.A., Hol P.R., van Andel A.C.J., Lutz E.T.G., and Gruys E. Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab. Invest. 56 (1987) 544-549
31. Ganowiak K., Hultman P., Engström U., Gustavsson A., and Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem. Biophys. Res. Commun. 199 (1994) 306-312
32. Johan K., Westermark G.T., Engström U., Gustavsson A., Hultman P., and Westermark P. Acceleration of AA-amyloidosis by amyloid-like synthetic fibrils. Proc. Natl. Acad. Sci. USA 95 (1998) 2558-2563
33. Cohen, A.S. and Cathcart, E.S. (1972) Casein-induced experimental amyloidosis in: Nutritional Pathology. Meth. Achievm. Exp. Path. vol. 6 (Bajusz, E. and Jasmin, G., Eds.), pp. 207-242, Karger, Basel.
34. Sørby R., Espenes A., Landsverk T., and Westermark G. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor. Amyloid 15 (2008) 21-29
35. Higuchi K., Kogishi K., Wang J., Chen X., Chiba T., Matsushita T., Hoshii Y., Kawano H., Ishihara T., Yokota T., and Hosokawa M. Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab. Invest. 78 (1998) 1535-1542
36. Xing Y., Nakamura A., Chiba T., Kogishi K., Matsushita T., Li F., Guo Z., Hosokawa M., Mori M., and Higuchi K. Transmission of mouse senile amyloidosis. Lab. Invest. 81 (2001) 493-499
37. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D.J., and Alpers M.P. Kuru in the 21st century - an acquired human prion disease with very long incubation period. Lancet 367 (2006) 2068-2074
38. Chiocchetti R., Mazzuoli G., Albanese V., Mazzoni M., Clavenzani P., Lalatta-Costerbosa G., Lucchi M.L., Di Guardo G., Marruchella G., and Furness J.B. Anatomical evidence for ileal Peyer's patches innervation by enteric nervous system: a potential route for prion neuroinvasion?. Cell Tissue Res. 332 (2008) 185-194
39. Aguzzi A., and Heikenwalder M. Patogenesis of prion diseases: current status and future outlook. Nat. Rev. 4 (2006) 765-775
40. Sponarova J., Nyström S., and Westermark G.T. AA-amyloidosis can be transferred by peripheral blood monocytes. PLoS ONE 3 (2008) e3308
41. Zhang B., Une Y., Fu X., Yan J., Ge F., Yao J., Sawashita J., Mori M., Tomozawa H., Kametani F., and Higuchi K. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc. Natl. Acad. Sci. USA 105 (2008) 7263-7268
42. Benditt E.P. The structure of amyloid protein AA and evidence for a transmissible factor in the origin of amyloidosis. In: Wegelius O., and Pasternack A. (Eds). Amyloidosis (1976), Academic Press, London 323-331
43. Neimanis A., Gavier-Widén D., Leighton F., Bollinger T., Rocke T., and Mörner T. An outbreak of type C botulism in herring gulls (Larus argentatus) in southeastern Sweden. J. Wildlife Dis. 43 (2007) 327-336
44. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 354 (1999) 317-323
45. Wadsworth J.D.F., Joiner S., Linehan J.M., Asante E.A., Brandner S., and Collinge J. The origin of the prion agent of kuru: molecular and biological strain typing. Phil. Trans. R. Soc. B 363 (2008) 3747-3753
46. Rochet J.-C., and Lansbury P.T.J. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10 (2000) 60-68
47. Shirahama T., Lawless O.J., and Cohen A.S. Heterologous transfer of amyloid - human to mouse. Proc. Soc. Exp. Biol. Med. 130 (1969) 516-519
48. Liu Y., Cui D., Hoshii Y., Kawano H., Une Y., Gondo T., and Ishihara T. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides. Scand. J. Immunol. 66 (2007) 495-500
49. Cui D., Kawano H., Hoshii Y., Liu Y., and Ishihara T. Acceleration of murine AA amyloid deposition by bovine fibrils and tissue homogenates. Amyloid 15 (2008) 77-83
50. Scott MR P.D., Nguyen H.O., Dearmond S.J., and Prusiner SB. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J. Virol. 79 (2005) 5259-5271
51. Llewelyn C.A., Hewitt P.E., Knight R.S.G., Amar K., Cousens S., Mackenzie J., and Will R.G. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
52. Wroe S.J., Pal S., Siddique D., Hyare H., Macfarlane R., Joiner S., Linehan J.M., Brandner S., Wadsworth J.D.F., Hewitt P., and Collinge J. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368 (2006) 2061-2067
53. Brown P. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13 Suppl. 5 (2007) 33-40
54. Westermark P., and Westermark G.T. Reflections on amyloidosis in Papua New Guinea. Phil. Trans. R. Soc. B 363 (2008) 3701-3705
55. Tojo K., Tokuda T., Hoshii Y., Fu X., Higuchi K., Matsui T., Kametani F., and Ikeda S.-I. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid 12 (2005) 103-108
56. Solomon A., Richey T., Murphy C.L., Weiss D.T., Wall J.S., Westermark G.T., and Westermark P. Amyloidogenic potential of foie gras. Proc. Natl. Acad. Sci. USA 104 (2007) 10998-11001
57. Hawkins P.N., and Pepys M.B. A primed state exists in vivo following histological regression of amyloidosis. Clin. Exp. Immunol. 81 (1990) 325-328
58. Collinge J., Whitfield J., McKintosh E., Frosh A., Mead S., Hill A.F., Brandner S., Thomas D., and Alpers M.P. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Phil. Trans. R. Soc. B 363 (2008) 3725-3739
59. Kenney J.M., Knight D., Wise M.J., and Vollrath F. Amyloidogenic nature of spider silk. Eur. J. Biochem. 269 (2002) 4159-4163
60. +), a heritable prion-like factor of S. cerevisiae. Cell 89 (1997) 811-819
61. Chapman M.R., Robinson L.S., Pinkner J.S., Roth R., Heuser J., Hammar M., Normark S., and Hultgren S.J. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295 (2002) 851-855
62. Kisilevsky R., Lemieux L., Boudreau L., Yang D.S., and Fraser P. New clothes for amyloid enhancing factor (AEF): silk as AEF. Amyloid 6 (1999) 98-106
63. Lundmark K., Westermark G.T., Olsén A., and Westermark P. Protein fibrils in nature can enhance AA amyloidosis in mice: Cross-seeding as a disease mechanism. Proc. Natl. Acad. Sci. USA 102 (2005) 6098-6102
64. Zhang S., Holmes T., DiPersio M., Hynes R.O., Su X., and Rich A. Self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterials 16 (1995) 1385-1393
65. Ellis-Behnke R.G., Liang Y.X., You S.W., Tay D.K., Zhang S., So K.F., and Schneider G.E. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl. Acad. Sci. USA 103 (2006) 5054-5059
66. O'Nuallain B., Acero L., Williams A.D., Koeppen H.P., Weber A., Schwarz H.P., Wall J.S., Weiss D.T., and Solomon A. Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. Biochemistry 47 (2008) 12254-12256
67. Booth D.R., Booth S.E., Gillmore J.D., Hawkins P.N., and Pepys M.B. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 5 (1998) 262-265
68. Yamada T., Okuda Y., Takasugi K., Wang L., Marks D., Benson M.D., and Kluve-Beckerman B. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid 10 (2003) 7-11
69. Westermark P., Sletten K., and Eriksson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab. Invest. 41 (1979) 427-431
70. Falck H.M., Törnroth T., and Wegelius O. Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria. Clin. Nephrol. 19 (1983) 137-142
71. Westermark G.T., Sletten K., and Westermark P. Massive vascular AA-amyloidosis: a histologically and biochemically distinctive subtype of reactive systemic amyloidosis. Scand. J. Immunol. 30 (1989) 605-613
72. Westermark G.T., Sletten K., Grubb A., and Westermark P. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am. J. Pathol. 137 (1990) 377-383
73. Jones E.M., and Surewicz W.K. Fibril conformation as the basis of species-and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121 (2005) 63-72
74. Weissmann C. Birth of a prion: spontaneous generation revisited. Cell 122 (2005) 165-168
75. King C.-Y., and Diaz-Avalos R. Protein-only transmission of three yeast prion strains. Nature 428 (2004) 319-323
76. Tanaka M., Chien P., Naber N., Cooke R.A., and Weissmann J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428 (2004) 323-328